Grace Therapeutics, Inc. Payments to Acquire Machinery and Equipment
Grace Therapeutics, Inc. (GRCE) reported Payments to Acquire Machinery and Equipment of $0 for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMachineryAndEquipment · last filed 2025-06-23
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2024-03-31 was $22.00K, a 175.00% increase year-over-year.
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2023-12-31 was $0.00.
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2023-03-31 was $8.00K.
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for the quarter ending 2022-12-31 was $0.00.
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for fiscal 2024 was $22.00K, a 29.41% increase from fiscal 2023.
- Grace Therapeutics, Inc. payments to acquire machinery and equipment for fiscal 2023 was $17.00K.
| Period end | Payments to Acquire Machinery and Equipment 3 month | Payments to Acquire Machinery and Equipment 6 month | Payments to Acquire Machinery and Equipment 9 month | Payments to Acquire Machinery and Equipment 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-06-23 | |||
| 2024-03-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | $22.00K derived: sum of 2 quarters · filed 2025-06-23 | $22.00K 10-K · filed 2025-06-23 | |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $0.00 10-Q · filed 2024-02-12 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |||
| 2023-03-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $8.00K derived: sum of 2 quarters · filed 2024-06-21 | $17.00K 10-K · filed 2024-06-21 | |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $9.00K 10-Q · filed 2024-02-12 | ||
| 2022-09-30 | $9.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |